George D Dangas

researcher

George D Dangas is …
instance of (P31):
humanQ5

External links are
P269IdRef ID221095411
P244Library of Congress authority IDn2007185345
P8189National Library of Israel J9U ID987007314607305171
P496ORCID iD0000-0001-7502-8049
P214VIAF ID68392136

P735given nameGeorgeQ15921732
GeorgeQ15921732
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q570254531-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration
Q376954142009 Focused updates to guidelines in ST-elevation myocardial infarction and percutaneous coronary intervention: application to interventional cardiology
Q91304723A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement
Q51219587A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique".
Q43049810A risk score to predict bleeding in patients with acute coronary syndromes
Q28285964A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation
Q46000101A volumetric intravascular ultrasound comparison of early drug-eluting stent thrombosis versus restenosis.
Q37283092ASCERT: the American College of Cardiology Foundation--the Society of Thoracic Surgeons Collaboration on the comparative effectiveness of revascularization strategies
Q45137335Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale
Q51793900Acute and long-term outcomes of cutting balloon angioplasty followed by gamma brachytherapy for in-stent restenosis.
Q77439600Acute angiographic and clinical results of the NIR w/SOX stent
Q44830908Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model
Q51145784American College of Cardiology Annual Scientific Session 2010: update in interventional cardiology.
Q80257706An evaluation of fluoroscopy time and correlation with outcomes after percutaneous coronary intervention
Q41960243Analysis of biomarkers for risk of acute kidney injury after primary angioplasty for acute ST-segment elevation myocardial infarction: results of the HORIZONS-AMI trial
Q42792264Angiographic complications and post‐PCI myocardial enzyme elevation: Brave new world revisited
Q46475076Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention
Q40458505Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial).
Q31141831Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials
Q83637005Angioscopic and virtual histology intravascular ultrasound characteristics of culprit lesion morphology underlying coronary artery thrombosis
Q37775915Antegrade, retrograde, and combination strategies for chronic total occlusions
Q47204835Antithrombotic Treatment after Transcatheter Heart Valves Implant
Q33446308Antithrombotic strategy variability in ATrial fibrillation and obstructive coronary disease revascularized with PCI-rationale and study design of the prospective observational multicenter AVIATOR 2 registry
Q51170781Art and Science of Cerebrovascular Event Prevention After Transcatheter Aortic Valve Replacement.
Q89423195Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention
Q81514556Assessing intermediate left main coronary lesions using intravascular ultrasound
Q47827567Assessment of trans-aortic pressure gradient using a coronary pressure wire in patients with mechanical aortic and mitral valve prostheses.
Q51831131Association among leukocyte count, mortality, and bleeding in patients with non-ST-segment elevation acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] trial).
Q38639061Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study
Q52373769Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study.
Q34974622Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial
Q38460595B-type natriuretic peptide and risk of contrast-induced acute kidney injury in acute ST-segment-elevation myocardial infarction: a substudy from the HORIZONS-AMI trial
Q41751821Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry).
Q90310416Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial
Q46648595Bifurcation coronary lesions treated with the "crush" technique: an intravascular ultrasound analysis
Q33503488Bifurcation stenting with drug-eluting stents: a systematic review and meta-analysis of randomised trials.
Q49958158Bioresorbable Vascular Scaffolds in Women
Q40989593Bivalirudin Is Associated With Improved In-Hospital Outcomes Compared With Heparin in Percutaneous Vascular Interventions: Observational, Propensity-Matched Analysis From the Premier Hospital Database
Q41205746Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial
Q28281179Bivalirudin during primary PCI in acute myocardial infarction
Q33400450Bivalirudin for primary percutaneous coronary intervention in acute myocardial infarction: the HORIZONS-AMI trial
Q28256871Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial
Q33428208Bivalirudin or Heparin Treatment During Transcatheter Valve Interventions: Where are we Now?
Q53151867Bleeding After Aortic Valve Replacement Matters: Important Mortality Risk.
Q38380420COCATS 4 Task Force 10: Training in Cardiac Catheterization
Q52984236Can Coronary Stent Implantation Complexity Become an Intuitive and Useful Factor to Tailor DAPT Duration?
Q48099035Cardiac enzyme elevation after coronary revascularization.
Q36983402Cardiovascular morbidity and mortality of the metabolic syndrome
Q96293193Cardiovascular outcomes after percutaneous coronary intervention on bifurcation lesions with moderate to severe coronary calcium: A single-center registry study
Q39438758Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry).
Q48720669Cerebral Embolism During Transcatheter Aortic Valve Replacement: The BRAVO-3 MRI Study
Q38413579Cerebrovascular events after a primary percutaneous coronary intervention strategy for acute ST-segment-elevation myocardial infarction: analysis from the HORIZONS-AMI Trial
Q52643133Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study.
Q46982016Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy).
Q47597302Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI.
Q83444440Classification and potential mechanisms of intravascular ultrasound patterns of stent fracture
Q42822404Clinical Impact of Enhanced Inhibition of P2Y12-Mediated Platelet Aggregation in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
Q35758154Clinical Outcome After DK Crush Versus Culotte Stenting of Distal Left Main Bifurcation Lesions: The 3-Year Follow-Up Results of the DKCRUSH-III Study
Q45916170Clinical investigation in ACS and PCI: shooting in the dark at a moving target.
Q43856223Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure
Q53598043Clinical outcome of nonculprit plaque ruptures in patients with acute coronary syndrome in the PROSPECT study.
Q91747798Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trial
Q46834205Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowings
Q46523338Clinical outcomes following stent thrombosis occurring in-hospital versus out-of-hospital: results from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial
Q45227523Clinical outcomes in the percutaneous coronary intervention of in-stent restenosis with everolimus-eluting stents.
Q28302425Clinical studies with sirolimus, zotarolimus, everolimus, and biolimus A9 drug-eluting stent systems
Q45087518Clopidogrel loading dose pre-PCI: how high?
Q89840320Combined and independent impact of coronary artery calcification and inflammation on risk for adverse cardiovascular events after percutaneous coronary intervention: Results from a large single-center registry
Q48937674Commentary: New insights into the risk factors of contrast-induced encephalopathy
Q36351313Comparative effectiveness of revascularization strategies
Q40603186Comparative efficacy of coronary artery bypass surgery vs. percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease with or without chronic kidney disease
Q42883088Comparison of Bivalirudin versus Bivalirudin plus glycoprotein IIb/IIIa inhibitor versus heparin plus glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes having percutaneous intervention for narrowed saphenous vein aorto-corona
Q60453532Comparison of Outcomes of Patients With ST-Segment Elevation Myocardial Infarction With Versus Without Previous Coronary Artery Bypass Grafting (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-
Q47432784Comparison of abciximab versus eptifibatide during percutaneous coronary intervention in ST-segment elevation myocardial infarction (from the HORIZONS-AMI trial).
Q82872483Comparison of angiographic and intravascular ultrasonic detection of myocardial bridging of the left anterior descending coronary artery
Q90779682Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER-collaboration
Q56982306Comparison of clinical and angiographic prognostic risk scores in patients with acute coronary syndromes: Analysis from the Acute Catheterization and Urgent Intervention Triage StrategY (ACUITY) trial
Q44065287Comparison of clinical outcomes using stents versus no stents after percutaneous coronary intervention for proximal left anterior descending versus proximal right and left circumflex coronary arteries
Q79838359Comparison of differences in outcome after percutaneous coronary intervention in men versus women <40 years of age
Q51806173Comparison of effect of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions on risk of hemorrhagic stroke in patients ≥75 years of age versus those <75 years of age
Q75400017Comparison of frequency of hemorrhagic stroke in patients <75 years versus > or =75 years of age among patients receiving glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions
Q51837478Comparison of in-hospital and one-year outcomes after multiple coronary arterial stenting in patients > or =80 years old versus those <80 years old.
Q43510316Comparison of one-year outcomes after percutaneous coronary intervention among current smokers, ex-smokers, and nonsmokers
Q73246222Comparison of outcomes in men versus women having percutaneous coronary interventions in small coronary arteries
Q51027407Comparison of provisional 1-stent and 2-stent strategies in diabetic patients with true bifurcation lesions: the EES bifurcation study.
Q51638776Comparison of safety and efficacy between first and second generation of angio-seal closure devices in interventional patients.
Q34137536Comparison of six risk scores in patients with triple vessel coronary artery disease undergoing PCI: competing factors influence mortality, myocardial infarction, and target lesion revascularization
Q37019512Comparison of surgical pericardial drainage with percutaneous catheter drainage for pericardial effusion
Q51785128Comparison of the angiographic outcomes after beta versus gamma vascular brachytherapy for treatment of in-stent restenosis.
Q46873841Comparison of the effects of pretreatment with tirofiban, clopidogrel or both on the inhibition of platelet aggregation and activation in patients with acute coronary syndromes
Q44247305Complete vascular healing and sustained suppression of neointimal thickening after local delivery of advanced c-myc antisense at six months follow-up in a rabbit balloon injury model
Q33924170Composite outcomes in coronary bypass surgery versus percutaneous intervention
Q47673628Contemporary outcomes of rescue percutaneous coronary intervention for acute myocardial infarction: comparison with primary angioplasty and the role of distal protection devices (EMERALD trial).
Q38215340Contemporary overview and clinical perspectives of chronic total occlusions
Q60453518Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy
Q43064438Contrast-induced acute kidney injury. Underappreciated or a new marker of cardiovascular mortality?
Q45201786Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables
Q44781955Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis
Q41631482Coronary Artery Bypass Surgery Compared With Percutaneous Coronary Intervention for Proximal Left Anterior Descending Artery Treatment in Patients With Acute Coronary Syndrome: Analysis From the ACUITY Trial
Q38886576Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS.
Q37459124Coronary artery aneurysms after drug-eluting stent implantation
Q30419699Coronary artery calcification is inversely related to body morphology in patients with significant coronary artery disease: a three-dimensional intravascular ultrasound study
Q28194342Coronary artery spasm associated with a moderately severe atherosclerotic stenosis in the proximal LAD
Q88036703Coronary chronic total occlusions: How to dilate the tough ones
Q51352499Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes.
Q39360380Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration
Q73668666Correlation of coronary arterial remodeling determined by intravascular ultrasound with angiographic diameter reduction of 20% to 60%
Q45238081Creatine kinase-MB enzyme elevation and long-term clinical events after successful coronary stenting in lesions with ruptured plaque
Q38890003Culprit-lesion only versus complete multivessel percutaneous intervention in ST-elevation myocardial infarction: A systematic review and meta-analysis of randomized trials
Q38095795Current periprocedural anticoagulation in transcatheter aortic valve replacement: could bivalirudin be an option? Rationale and design of the BRAVO 2/3 studies
Q47833058D-dimer levels predict ischemic and hemorrhagic outcomes after acute myocardial infarction: a HORIZONS-AMI biomarker substudy
Q51741704Dedicated two-stent technique in complex bifurcation percutaneous coronary intervention with use of everolimus-eluting stents: the EES-bifurcation study.
Q44284349Deferoxamine enhances neovascularization and recovery of ischemic skeletal muscle in an experimental sheep model
Q34740055Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial
Q51749911Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach.
Q39515673Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes
Q42332217Diabetes mellitus and multivessel coronary artery disease: an ongoing battle for an ideal treatment strategy
Q42167544Dominant contribution of negative remodeling to development of significant coronary bifurcation narrowing
Q37301358Drug-eluting stents in the real world: how intravascular ultrasound can improve clinical outcome
Q40319620Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials
Q57132788Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry)
Q35963211Dual Antiplatelet Therapy Duration: A Review of Current Available Evidence
Q48356240Dual catheter technique for the treatment of severe coronary artery perforations
Q26852886Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials
Q38392725Early Stent Thrombosis and Mortality After Primary Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial Infarction: A Patient-Level Analysis of 2 Randomized Trials
Q54141528Editorial Comment—Hypotension After Carotid Revascularization
Q40112204Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: A Patient-Level Pooled Analysis of Randomized Controlled Trials
Q50188567Effect of Increasing Stent Length on 3-Year Clinical Outcomes in Women Undergoing Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents: Patient-Level Pooled Analysis of Randomized Trials From the WIN-DES Initiative
Q38380117Effect of Short Procedural Duration With Bivalirudin on Increased Risk of Acute Stent Thrombosis in Patients With STEMI: A Secondary Analysis of the HORIZONS-AMI Randomized Clinical Trial
Q51031387Effect of anemia on frequency of short- and long-term clinical events in acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial).
Q40300202Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials).
Q44108396Effect of percutaneous coronary interventions for in-stent restenosis in degenerated saphenous vein grafts without distal embolic protection
Q93079964Effect of stent diameter in women undergoing percutaneous coronary intervention with early- and new-generation drug-eluting stents: From the WIN-DES collaboration
Q84257672Effect of switching antithrombin agents for primary angioplasty in acute myocardial infarction: the HORIZONS-SWITCH analysis
Q48151897Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial
Q46711890Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis
Q46672411Effectiveness of the concomitant use of bivalirudin and drug-eluting stents (from the prospective, multicenter BivAlirudin and Drug-Eluting STents [ADEST] study).
Q47297262Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From a Patient-Level Pooled Analysis of Randomized Controlled Trials
Q33431313Effects of baseline and early acquired thrombocytopaenia on long-term mortality in patients undergoing percutaneous coronary intervention with bivalirudin
Q39035252Efficacy and safety of everolimus and zotarolimus-eluting stents versus first-generation drug-eluting stents in patients with diabetes: A meta-analysis of randomized trials
Q38781681Efficacy and safety of routine thrombus aspiration in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: An updated systematic review and meta-analysis of randomized controlled trials
Q53208811Endovascular treatment of infrarenal aortic stenosis: importance of multimodality imaging.
Q50725684Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents.
Q38119278Evolution of intravascular assessment of coronary anatomy and physiology: from ultrasound imaging to optical and flow assessment
Q102373871Excimer laser coronary atherectomy for uncrossable coronary lesions. A multicenter registry
Q38037668Facilitated/pharmaco-invasive approaches in STEMI.
Q41069073Factors Affecting Bleeding and Stent Thrombosis in Clinical Trials Comparing Bivalirudin With Heparin During Percutaneous Coronary Intervention
Q51654770Favorable effect of gamma-radiation for in-stent restenosis: effect of diabetes on angiographic and clinical outcomes.
Q51393862Female gender and mortality after percutaneous coronary intervention: results from a large registry.
Q46533338First-in-man 1-year clinical outcomes of the Catania Coronary Stent System with Nanothin Polyzene-F in de novo native coronary artery lesions: the ATLANTA (Assessment of The LAtest Non-Thrombogenic Angioplasty stent) trial
Q57486604Fourth universal definition of myocardial infarction (2018)
Q45395198Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction
Q51707931Gamma radiation for in-stent restenosis: effect of lesion length on angiographic and clinical outcomes.
Q42634785Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial
Q39438763Gender Differences in Associations Between Intraprocedural Thrombotic Events During Percutaneous Coronary Intervention and Adverse Outcomes
Q43957429Gender differences in clinical outcome after coronary artery stenting with use of glycoprotein IIb/IIIa inhibitors
Q51305480Gender differences in long-term clinical outcomes after percutaneous coronary intervention of chronic total occlusions.
Q41654886Gender-specific outcomes after balloon aortic valvuloplasty: Inhospital and long-term outcomes
Q46883865Gender-specific outcomes after sirolimus-eluting stent implantation
Q92315017Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry
Q50146799Guidelines for Patient-Reported Outcomes in Clinical Trial Protocols
Q67223888Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial
Q30450312High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study
Q37888541How serious a problem is bleeding in patients with acute coronary syndromes?
Q34943346How to diagnose, how to treat: renal artery stenosis-diagnosis and management
Q33789829Humanized mouse model of thrombosis is predictive of the clinical efficacy of antiplatelet agents
Q40774686Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study
Q40736980Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With Dr
Q34486268Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes: Pooled Analysis From the HORIZONS-AMI and ACUITY Trials
Q91748345Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents
Q40319115Impact of Diabetes Mellitus on Ischemic Events in Men and Women After Percutaneous Coronary Intervention
Q38378830Impact of Diabetes Mellitus on the Pharmacodynamic Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Acute Coronary Syndrome Patients Undergoing Ad Hoc Percutaneous Coronary Intervention
Q46262291Impact of Hemoglobin A1c Levels on Residual Platelet Reactivity and Outcomes After Insertion of Coronary Drug-Eluting Stents (from the ADAPT-DES Study).
Q57412725Impact of Major Bleeding on Long-Term Mortality in Anemic Versus Nonanemic Patients Undergoing Percutaneous Coronary Intervention Using Bivalirudin
Q50662100Impact of an integrated treatment algorithm based on platelet function testing and clinical risk assessment: results of the TRIAGE Patients Undergoing Percutaneous Coronary Interventions To Improve Clinical Outcomes Through Optimal Platelet Inhibiti
Q43069516Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial).
Q46368065Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions
Q51783108Impact of antithrombotic treatment on short-term outcomes after percutaneous coronary intervention for left main disease: a pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials.
Q33394100Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HO
Q43288786Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage str
Q44994395Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention
Q53597769Impact of coronary lesion complexity on drug-eluting stent outcomes in patients with and without diabetes mellitus: analysis from 18 pooled randomized trials.
Q44260544Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention.
Q54377389Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial).
Q85090019Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) t
Q90257344Impact of insulin treated and non-insulin-treated diabetes compared to patients without diabetes on 1-year outcomes following contemporary PCI
Q43918642Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents
Q56985462Impact of leukocyte count on mortality and bleeding in patients with myocardial infarction undergoing primary percutaneous coronary interventions: analysis from the Harmonizing Outcome with Revascularization and Stent in Acute Myocardial Infarction t
Q39639977Impact of major bleeding and blood transfusions after cardiac surgery: analysis from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial
Q51758758Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial.
Q83795968Impact of myocardial bridge on clinical outcome after coronary stent placement
Q53936363Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction.
Q92217180Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO-3 randomized trial
Q46496318Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy).
Q43709119Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stents
Q34060015Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data
Q48158581Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial
Q38938320Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry
Q84817753Impact of smoking on outcomes of patients with ST-segment elevation myocardial infarction (from the HORIZONS-AMI Trial)
Q93141850Impact of stent diameter on outcomes following percutaneous coronary intervention with second-generation drug-eluting stents: Results from a large single-center registry
Q75351724Impact of symptomatic peripheral arterial disease on 1-year mortality in patients undergoing percutaneous coronary interventions
Q53364967Impact of target vessel on long-term survival after percutaneous coronary intervention for chronic total occlusions.
Q34021163Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials
Q45982712Impact of thienopyridine administration prior to primary stenting in acute myocardial infarction.
Q39278248Impact of time to treatment on the effects of bivalirudin vs. glycoprotein IIb/IIIa inhibitors and heparin in patients undergoing primary percutaneous coronary intervention: insights from the HORIZONS-AMI trial
Q37812440In-stent restenosis in the drug-eluting stent era.
Q44067510Incidence and angiographic characteristics of patients with apical ballooning syndrome (takotsubo/stress cardiomyopathy) in the HORIZONS-AMI trial: an analysis from a multicenter, international study of ST-elevation myocardial infarction
Q33394098Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial
Q43443221Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI trial
Q38885545Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry
Q88461145Incidence, determinants and clinical impact of definite stent thrombosis on mortality in women: From the WIN-DES collaborative patient-level pooled analysis
Q38428199Incidence, predictors, and implications of reinfarction after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial
Q44684605Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study
Q91433521Influence of Final Kissing Balloon Inflation on Long-term Outcomes After PCI of Distal Left Main Bifurcation Lesions: Analysis From the EXCEL Trial
Q48096926Integrating invasive hemodynamic parameters into risk stratification of acute myocardial infarction and cardiogenic shock
Q33959229Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis model
Q73438377Intravascular brachytherapy for native coronary ostial in-stent restenotic lesions
Q40410810Intravascular ultrasonic assessment of stent diameters derived from manufacturer's compliance charts
Q83297062Intravascular ultrasonic differences between aorto-ostial and shaft narrowing in saphenous veins used as aortocoronary bypass grafts
Q80020261Intravascular ultrasound assessment of fibrous cap remnants after coronary plaque rupture
Q45253566Intravascular ultrasound assessment of lesions with target vessel failure after sirolimus-eluting stent implantation
Q84768530Intravascular ultrasound assessment of the incidence and predictors of edge dissections after drug-eluting stent implantation
Q79279183Intravascular ultrasound assessment of ulcerated ruptured plaques: a comparison of culprit and nonculprit lesions of patients with acute coronary syndromes and lesions in patients without acute coronary syndromes
Q43144683Intravascular ultrasound classification of plaque distribution in left main coronary artery bifurcations: where is the plaque really located?
Q38490870Intravascular ultrasound findings of early stent thrombosis after primary percutaneous intervention in acute myocardial infarction: a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) substudy
Q80960386Intravascular ultrasound study of patterns of calcium in ruptured coronary plaques
Q37122647Inverse relationship between body mass index and coronary artery calcification in patients with clinically significant coronary lesions
Q46000107Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chroni
Q43117188Is accurate intravascular ultrasound evaluation of the left circumflex ostium from a left anterior descending to left main pullback possible?
Q36252020Is surgery preferred for the diabetic with multivessel disease? Debate on revascularization strategy for diabetic patients with multivessel coronary artery disease.
Q48143822Ischemia-reperfusion injury and ischemic post-conditioning in acute myocardial infarction: Lost in translation
Q38023285Late stent thrombosis: the last remaining obstacle in coronary interventional therapy
Q91344896Leave nothing behind: Promising results for coronary drug-coated balloons in clinical practice
Q38443693Leukocyte count is a modulating factor for the mortality benefit of bivalirudin in ST-segment-elevation acute myocardial infarction: the HORIZONS-AMI trial
Q38704416Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration
Q38178840Long-term clinical outcomes after percutaneous coronary intervention for chronic total occlusions
Q46810032Long-term clinical outcomes after percutaneous coronary intervention for chronic total occlusions in elderly patients (≥75 years): five-year outcomes from a 1,791 patient multi-national registry
Q57214404Long-term clinical outcomes of percutaneous coronary intervention for chronic total occlusions in patients with versus without diabetes mellitus
Q73727652Long-term follow-up of patients after gamma intracoronary brachytherapy failure (from GAMMA-I, GAMMA-II, and SCRIPPS-III)
Q84974281Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocard
Q44721871Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial
Q43605422Long-term outcome of percutaneous coronary intervention for chronic total occlusions
Q45240001Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions
Q44252902MaXIMAl benefits in the elderly?
Q57764238Management of Patients after Acute Coronary Syndrome
Q38679410Meta-Analysis of Radial Versus Femoral Access for Percutaneous Coronary Interventions in Non-ST-Segment Elevation Acute Coronary Syndrome
Q53103119Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatmen
Q28191931Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting
Q38373158Meta-analysis of trials on mortality after percutaneous coronary intervention compared with medical therapy in patients with stable coronary heart disease and objective evidence of myocardial ischemia
Q38398190Meta-analysis on the impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcome
Q51689831Minimally invasive coronary artery bypass grafting versus stenting for patients with proximal left anterior descending coronary artery disease.
Q45287676Minimally invasive direct coronary artery bypass (MIDCAB) versus coronary artery stenting for elective revascularization of the left anterior descending artery
Q37188126Multivessel disease: percutaneous coronary intervention for classic coronary artery bypass grafting indications
Q46727655Necrotic core and its ratio to dense calcium are predictors of high-risk non-ST-elevation acute coronary syndrome
Q38986493Neurological Outcomes With Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Q74317542New-device angioplasty in women: clinical outcome and predictors in a 7,372-patient registry
Q50927625Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloon.
Q45158732Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation
Q45286576Novel site-specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis model
Q99610712One-year clinical outcomes in patients with chronic kidney disease treated with COMBO stents: From the COMBO collaboration
Q38951997One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study
Q27003223Open versus endovascular stent graft repair of abdominal aortic aneurysms: a meta-analysis of randomized trials
Q51167432Open versus endovascular stent graft repair of abdominal aortic aneurysms: do we need more randomized clinical trials?
Q43585011Optimal catchment area and primary PCI centre volume revisited: a single-centre experience in transition from high-volume centre to "mega centre" for patients with ST-segment elevation myocardial infarction
Q44650101Optimal final lumen area and predictors of target lesion revascularization after stent implantation in small coronary arteries
Q51150191Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasound.
Q43413010Outcome of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention during on- versus off-hours (a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-
Q51498928Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery.
Q51373166Outcomes of patients treated with triple antithrombotic therapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [
Q89077892Overlapping bio-absorbable scaffolds: Aim for D2D technique?
Q33357497PCI options in heparin-induced thrombocytopenia
Q44546500Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction
Q53311236Patients with 3-vessel coronary artery disease and impaired ventricular function undergoing PCI with Impella 2.5 hemodynamic support have improved 90-day outcomes compared to intra-aortic balloon pump: a sub-study of the PROTECT II trial.
Q90908067Patterns and Impact of Dual Antiplatelet Cessation on Cardiovascular Risk After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes
Q38938312Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry
Q52632790Percutaneous closure of patent foramen ovale vs. medical treatment for patients with history of cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials.
Q33361891Percutaneous interventions in patients with immune-mediated heparin-induced thrombocytopenia
Q38076852Percutaneous recanalization of chronic total occlusions: wherein lies the body of proof?
Q36282753Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I.
Q36288750Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part II.
Q36254967Percutaneous recanalization of chronically occluded coronary arteries: procedural techniques, devices, and results
Q37909255Percutaneous revascularization of left main: role of imaging, techniques, and adjunct pharmacology
Q53253517Performance of currently available risk models in a cohort of mechanically supported high-risk percutaneous coronary intervention--From the PROTECT II randomized trial.
Q53206956Physiological correlates of densely calcified coronary lesions on coronary computed tomography angiography among patients with low-to-intermediate coronary artery disease likelihood.
Q89125284Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation: From the ADAPT-DES Study
Q91635345Positioning of self-expanding transcatheter valve prostheses
Q43897723Postprocedure creatine kinase-MB elevation and baseline left ventricular dysfunction predict one-year mortality after percutaneous coronary intervention
Q39619295Prediction of 1-year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient-level pooled analysis from three randomized trials
Q34169161Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the National Cardiovascular Data Registry
Q85209593Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trial
Q56983614Predictors and implications of stent thrombosis in non-ST-segment elevation acute coronary syndromes: the ACUITY Trial
Q45100441Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial).
Q35954660Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study).
Q38454235Predictors of suboptimal TIMI flow after primary angioplasty for acute myocardial infarction: results from the HORIZONS-AMI trial
Q35075629Premature coronary artery disease in systemic lupus erythematosus with extensive reocclusion following coronary artery bypass surgery
Q100407259Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI registry
Q102381687Prevalence and prognostic impact of hsCRP elevation are age-dependent in women but not in men undergoing percutaneous coronary intervention
Q48103275Prevalence, correlates, and impact of coronary calcification on adverse events following PCI with newer-generation DES: Findings from a large multiethnic registry.
Q50645391Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Procedures: Evidence From a Hierarchical Bayesian Network Meta-Analysis of 124 Trials and 28 240 Patients.
Q83221765Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial
Q84682483Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial
Q80193954Prognostic significance of cerebrovascular and peripheral arterial disease in patients having percutaneous coronary interventions
Q46318609Prognostic utility of the SYNTAX score in patients with single versus multivessel disease undergoing percutaneous coronary intervention (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] trial).
Q38212318Prognostic value of access site and nonaccess site bleeding after percutaneous coronary intervention: a cohort study in ST-segment elevation myocardial infarction and comprehensive meta-analysis
Q54114442Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial.
Q39039443Prosthetic Heart Valve Thrombosis
Q77480632Quantitative angiographic methods for appropriate end-point analysis, edge-effect evaluation, and prediction of recurrent restenosis after coronary brachytherapy with gamma irradiation
Q50154495Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial
Q35056263Radiocontrast nephropathy: identifying the high-risk patient and the implications of exacerbating renal function
Q46154973Real world safety and efficacy of the Janus Tacrolimus-Eluting stent: long-term clinical outcome and angiographic findings from the Tacrolimus-Eluting STent (TEST) registry
Q85763381Reasonable incomplete revascularisation after percutaneous coronary intervention: the SYNTAX Revascularisation Index
Q39890592Recommendations for successful training on methods of delivery of biologics for cardiac regeneration: a report of the International Society for Cardiovascular Translational Research
Q90768291Redefining landmarks to improve #safefemoral outcomes
Q91304729Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement
Q40806431Relation Between Platelet Count and Platelet Reactivity to Thrombotic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study
Q51842734Relation between the degree of procedural anticoagulation and complications after coronary stent implantation.
Q40252817Relation of Baseline Hemoglobin Levels and Adverse Events in Patients With Acute Coronary Syndromes (from the Acute Catheterization and Urgent Intervention Triage strategY and Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardia
Q51689829Relation of final lumen dimensions in saphenous vein grafts after stent implantation to outcome.
Q85614047Relationship between biomarkers and subsequent bleeding risk in ST-segment elevation myocardial infarction patients treated with paclitaxel-eluting stents: a HORIZONS-AMI substudy
Q83785783Relationship between biomarkers and subsequent clinical and angiographic restenosis after paclitaxel-eluting stents for treatment of STEMI: a HORIZONS-AMI substudy
Q44640403Relationship between the intensity of heparin anticoagulation and clinical outcomes in patients receiving glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction
Q50086189Reply: Bioresorbable Scaffold Thrombosis: A Multifactorial Phenomenon Also Involving Hypersensitivity Inflammation?
Q46005634Reply: TAVR and Stroke Prevention: Importance of Cerebral Embolic Protection Device Data.
Q40752196Resistant in-stent restenosis in the drug eluting stent era.
Q44660132Restenosis due to underexpansion of sirolimus‐eluting stent in a bifurcation lesion
Q37615614Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards
Q38003335Revascularization of unprotected left main coronary artery disease: strategy selection and systematic risk assessment
Q37862838Revascularization strategies for stable multivessel and unprotected left main coronary artery disease: from BARI to SYNTAX.
Q52584692Role of Invasive Functional Assessment in Surgical Revascularization of Coronary Artery Disease.
Q45969326Role of PLA2 polymorphism on clinical events after percutaneous coronary intervention.
Q43268517Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial
Q35863530Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions
Q100757035Rolling the rock uphill during left main stenting: The Sisyphus myth in percutaneous coronary intervention?
Q39764608Safety and Efficacy of Bivalirudin in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: From the REPLACE-2, ACUITY and HORIZONS-AMI Trials
Q60453545Safety and Efficacy of High- Versus Low-Dose Aspirin After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction
Q40812182Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Artery Revascularization: From the WIN-DES Collaborative Patient-Level Pooled Analysis
Q40126785Safety and Efficacy of New-Generation Drug-Eluting Stents in Women at High Risk for Atherothrombosis: From the Women in Innovation and Drug-Eluting Stents Collaborative Patient-Level Pooled Analysis
Q91756914Safety and efficacy of bivalirudin monotherapy in patients with non-ST-segment elevation acute coronary syndromes with positive biomarkers undergoing percutaneous coronary intervention: a report from the Acute Catheterization and Urgent Intervention
Q94678370Safety and efficacy of the bioabsorbable polymer everolimus-eluting stent versus durable polymer drug-eluting stents in high-risk patients undergoing PCI: TWILIGHT-SYNERGY
Q37760031Safety issues related to treating bifurcation lesions.
Q53544484Second-generation drug-eluting stents and bioresorbable vascular scaffolds in patients with diabetes.
Q90554791Sex differences in 1-year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration
Q50229683Sex differences in the effect of diabetes mellitus on platelet reactivity and coronary thrombosis: From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study
Q39619291Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With Stents
Q39071281Sex-Based Differences in Outcomes With Transcatheter Aortic Valve Therapy: TVT Registry From 2011 to 2014.
Q51121376Sex-based differences in bleeding and long term adverse events after percutaneous coronary intervention for acute myocardial infarction: three year results from the HORIZONS-AMI trial.
Q46834201Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era.
Q51687151Short- and long-term results after multivessel stenting in diabetic patients.
Q39952140Significant radiation reduction in interventional fluoroscopy using a novel eye controlled movable region of interest
Q73438837Sirolimus-coated Stent Prevents Neointimal Proliferation
Q38396170Six Versus 12 Months of Dual Antiplatelet Therapy After Implantation of Biodegradable Polymer Sirolimus-Eluting Stent: Randomized Substudy of the I-LOVE-IT 2 Trial
Q33497692Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis
Q57764282Spontaneous coronary artery dissection
Q44055095Stent thrombosis after primary angioplasty for STEMI in relation to non-adherence to dual antiplatelet therapy over time: results of the HORIZONS-AMI trial
Q38262362Stent thrombosis: a clinical perspective
Q46420633Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study
Q28278561Strategies for multivessel revascularization in patients with diabetes
Q41347812Stroke prevention in valvular heart disease: from the procedure to long-term management
Q56594047Subtotal Occlusion of Left Anterior Coronary Artery in a Professional Athlete
Q51577658Successful use of the frontrunner catheter in the treatment of in-stent coronary chronic total occlusions.
Q38563063Surgical Revascularization versus Percutaneous Coronary Intervention and Optimal Medical Therapy in Diabetic Patients with Multi-Vessel Coronary Artery Disease
Q44776900Systemic targeted delivery of antisense with perflourobutane gas microbubble carrier reduced neointimal formation in the porcine coronary restenosis model
Q50976600TAVR Through Heavily Calcified Aorta Following Atheroma Retrieval With the "Elevator" Technique.
Q49391876TAVR for Severe Aortic Regurgitation: Advancing the Frontier
Q91799266Temporal trends of survival and utilization of mechanical circulatory support devices in patients with in-hospital cardiac arrest secondary to ventricular tachycardia/ventricular fibrillation
Q35954502The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entry
Q46514295The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale
Q26741071The current role and future prospects of D-dimer biomarker
Q43833770The impact of multivessel disease with and without a co-existing chronic total occlusion on short- and long-term mortality in ST-elevation myocardial infarction patients with and without cardiogenic shock
Q92679641The importance of the Heart Team evaluation before transcatheter aortic valve replacement: Results from the BRAVO-3 trial
Q37830053The optimal pharmacological formula for percutaneous coronary intervention
Q48922947The predictive value and evolution of N-terminal pro-B-type natriuretic peptide levels following transcutaneous aortic valve implantation
Q57796301The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry
Q52596393The quest for a "diabetic" stent.
Q91534770The quest for the optimal treatment for in-stent restenosis
Q35171837The relationship among extent of lipid-rich plaque, lesion characteristics, and plaque progression/regression in patients with coronary artery disease: a serial near-infrared spectroscopy and intravascular ultrasound study
Q43202648The relative effects of abciximab and tirofiban on platelet inhibition and C-reactive protein during coronary intervention.
Q38896299The role of HDL in plaque stabilization and regression: basic mechanisms and clinical implications
Q37402192The use of vascular closure devices and impact on major bleeding and net adverse clinical events (NACEs) in balloon aortic valvuloplasty: a sub-analysis of the BRAVO study
Q47903684Thrombo-embolic prevention after transcatheter aortic valve implantation
Q36419388Thrombosis after implantation of drug-eluting stents.
Q38886590Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study
Q38886583Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention: Results From the PARIS Registry
Q91616328Transcatheter Cardiovascular Therapeutics 2018
Q90475842Transcatheter valve-in-valve for failing bioprosthetic aortic valve: Usually a good idea
Q91535841Transcatheter valves are a viable option for degenerative surgical mitral bioprostheses
Q93204431Transfemoral PCI skill: Use it or lose it.….But #RadialFirst
Q73250204Transplantation of autologous endothelial cells induces angiogenesis
Q38835461Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention
Q51157749Treatment of coronary artery perforations complicating percutaneous coronary intervention with a polytetrafluoroethylene-covered stent graft.
Q46911870Treatment of restenotic drug-eluting stents: an intravascular ultrasound analysis.
Q40454454Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study.
Q83078618Two-year safety and effectiveness of sirolimus-eluting stents (from a prospective registry)
Q37465644Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis
Q78772918Usefulness of atrial fibrillation as a marker of outcome after percutaneous coronary intervention
Q47393557Usefulness of the angiographic pattern of in-stent restenosis in predicting the success of gamma vascular brachytherapy
Q50096699Validation of contemporary risk scores in predicting coronary thrombotic events and major bleeding in patients with acute coronary syndrome after drug-eluting stent implantations
Q47998899Valvular Heart Disease in Women, Differential Remodeling, and Response to New Therapies
Q36131334Vascular closure devices: a review of their use after invasive procedures
Q35885937Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis
Q80845993Vascular remodeling and plaque composition between focal and diffuse coronary lesions assessed by intravascular ultrasound
Q51098019Volumetric intravascular ultrasound assessment of neointimal hyperplasia and nonuniform stent strut distribution in sirolimus-eluting stent restenosis.
Q53353396What to do when a patient with coronary stents needs surgery?
Q50061984White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry).
Q91054943Why females get better longer-term outcomes with TAVR

Search more.